Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)-Reference-Cited by-同舟云学术

Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)

Published:2009-12 Issue:11 Volume:104 Page:1457-1464
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Zhao Xue-Qiao,Krasuski Richard A.,Baer Jefferson,Whitney Edwin J.,Neradilek Blazej,Chait Alan,Marcovina Santica,Albers John J.,Brown B. Greg

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease;Brown;N Engl J Med,2001

2. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B;Brown;N Engl J Med,1990

3. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events;Whitney;Ann Intern Med,2005

4. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);JAMA,2001

5. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT);Robins;Diabetes Care,2003

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials;European Heart Journal - Cardiovascular Pharmacotherapy;2020-11-02

2. Atherosclerosis: Making a U Turn;Annual Review of Medicine;2020-01-27

3. 2018 Guidelines for the management of dyslipidemia;The Korean Journal of Internal Medicine;2019-07-01

4. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?;Current Vascular Pharmacology;2018-03-26

5. Niacin and heart disease prevention: Engraving its tombstone is a mistake;Journal of Clinical Lipidology;2017-11